Masimo Escapes FCA Row Over Allegedly Shoddy Devices

Law360, New York (October 3, 2013, 4:59 PM EDT) -- Patient-monitoring technology firm Masimo Corp. scored a victory Wednesday when a California federal court freed it from a False Claims Act suit over Medicare reimbursements for allegedly defective medical devices, finding the relators had not sufficiently proven their claims.

U.S. District Judge Cormac J. Carney granted Masimo’s summary judgment motion in a case brought by former Masimo sales representatives who sold the noninvasive hemoglobin devices called Radical-7, Pronto and Pronto-7. The relators had claimed Masimo fraudulently led a number of government programs to pay reimbursements for...
To view the full article, register now.